title: Echinocandins: production and applications.
abstract: The first echinocandin-type antimycotic (echinocandin B) was discovered in the 1970s. It was followed by the isolation of more than 20 natural echinocandins. These cyclic lipo-hexapeptides are biosynthesized on non-ribosomal peptide synthase complexes by different ascomycota fungi. They have a unique mechanism of action; as non-competitive inhibitors of β-1,3-glucan synthase complex they target the fungal cell wall. Results of the structure-activity relationship experiments let us develop semisynthetic derivatives with improved properties. Three cyclic lipohiexapeptides (caspofungin, micafungin and anidulafungin) are currently approved for use in clinics. As they show good fungicidal (Candida spp.) or fungistatic (Aspergillus spp.) activity against the most important human pathogenic fungi including azole-resistant strains, they are an important addition to the antifungal armamentarium. Some evidence of acquired resistance against echinocandins has been detected among Candida glabrata strains in recent years, which enhanced the importance of data collected on the mechanism of acquired resistance developing against the echinocandins. In this review, we show the structural diversity of natural echinocandins, and we summarize the emerging data on their mode of action, biosynthesis and industrial production. Their clinical significance as well as the mechanism of natural and acquired resistance is also discussed.
authors: Department of Microbial Biotechnology and Cell Biology, Faculty of Science and Technology, University of Debrecen, 4032 Debrecen, Hungary. emri.tamas@science.unideb.hu
authors: Tamás
authors: T
authors: Emri
authors: László
authors: L
authors: Majoros
authors: Viktória
authors: V
authors: Tóth
authors: István
authors: I
authors: Pócsi
mesh_terms: D000935:Antifungal Agents / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D053898:Biosynthetic Pathways / Q000235:genetics; D001709:Biotechnology / Q000379:methods; D025141:Drug Resistance, Fungal; D054714:Echinocandins / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology; D013678:Technology, Pharmaceutical / Q000379:methods
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins